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Summary
Background:  The  pathogenicity  of  Staphylococcus  aureus  is  based  on  the  production
of  various  virulence  factors.  The  frequency  of  these  factors  can  markedly  differ
according  to  the  geographical  region.
Materials  and  methods:  In  this  study,  we  investigated  the  prevalence  of  two  fre-
quent  isoforms  of  exfoliative  toxins  and  mecA  genes  using  PCR  in  197  clinical  isolates
obtained  from  clinical  samples  during  the  years  2011  and  2012.  The  samples  were
obtained  from  an  educational  hospital  in  northern  Tehran,  Iran.  In  addition,  the
antibiotic  susceptibility  pattern  was  studied  for  each  isolate  using  the  disc  diffusion
method.
Results:  In  this  study,  186  (94.4%),  15  (7.6%)  and  172  (86.3%)  of  the  197  isolates
expressed  the  eta, etb  and  mecA genes,  respectively.  In  addition,  164  (88.2%)  and
12  (80%)  strains,  which  harbored  the  eta  and  etb  genes,  respectively,  were  MRSA
(methicillin  resistant  S.  aureus).  Furthermore,  the  prevalence  of  the  mecA, eta  and
etb  genes  was  higher  among  the  wound  samples  (61.2%,  55.8%  and  6.09%,  respec-
tively).  We  observed  high  rates  of  MDR  (multi  drug  resistance)  among  our  isolates.
A  signiﬁcant  correlation  was  detected  between  the  presence  of  the  mecA gene
and  the  resistance  to  oxacillin,  gentamicin,  kanamycin,  erythromycin,  tetracycline,
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cotrimoxazole,  clindamycin,  and  cephazolin  as  well  as  the  multi-drug  resistant  prop-
erty  (P  <  0.05).  In  addition  to  penicillin,  the  MDR  properties  and  resistances  to  the
tested  antibiotics  in  the  etb-positive  strains  were  signiﬁcantly  lower  compared  to  the
 0.05).
ence  of  the  eta, etb  and  mecA  genes  might  be  due  to  the
n.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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Conclusions:  The  preval
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Introduction
Staphylococcus  aureus  is  known  as  the  main  noso-
comial  pathogen  due  to  its  ability  to  generate  a
wide range  of  virulence  factors,  such  as  extra-
cellular protein  toxins  and  a  large  number  of
anti-microbial resistance  compounds.  Accordingly,
the pathogenicity  of  the  organism  causes  various
diseases, from  mild  skin  and  tissue  infections  or
food poisoning  to  severe  systematic  infections.  In
addition,  harmful  super-antigenic  toxins,  such  as
enterotoxins  and  tsst-1  and  exfoliative  toxin  (ET),
which is  a  pyrogenic  exoprotein,  result  in  a  dan-
gerous  disorder  known  as  staphylococcal  scalded
skin syndrome.  This  type  of  blistering  skin  disease
is divided  into  two  clinical  forms,  the  localized  and
generalized  forms.  The  generalized  form,  which  is
called Ritters  disease,  frequently  occurs  in  infants
and children  [1]. However,  the  localized  form,
which is  termed  Bullous  impetigo,  can  afﬂict  at  all
ages. Moreover,  in  the  Bullous  impetigo  form,  the
exfoliative  toxin,  which  produces  localized  strains,
can locally  affect  the  skin.  In  contrast,  in  Ritters
syndrome, the  infecting  strains  are  located  at dis-
tant sites,  and  the  target  tissue  receives  the  toxin
via the  bloodstream  [2].
Three isoforms  of  ET,  ETA,  ETB  and  ETD,  which
are encoded  by  the  eta,  etb  and  etd  genes,  respec-
tively, are  capable  of  cleaving  desmogelin  1,  a
cadherin  protein,  which  mediates  cell—cell  adhe-
sion in  keratinocytes.  The  ETA  and  ETB  toxins  are
associated  with  the  occurrence  of  staphylococ-
cal scaled  skin  syndrome  (SSSS)  [3].  Despite  the
genetic similarity  and  biological  function  equality,
ETA and  ETB  differ  in  their  immunological  charac-
teristics and  location  of  encoding  genes.  The  eta
gene has  a  chromosomal  origin  that  is  integrated
by prophages,  whereas  the  etb  gene  is  a  plasmidic
gene [4].  Furthermore,  a  higher  frequency  of  the
eta gene  has  been  reported  among  the  S.  aureus
strains [1].
To the  best  of  our  knowledge,  there  is  no  infor-
mation on  the  prevalence  of  S.  aureus  strains
carrying the  eta  and  etb  genes  in  isolations
obtained from  clinical  samples  in  Iran.  In  this  study,
P
m
Ge  aimed  to  assess  the  prevalence  of  S.  aureus
trains harboring  the  exfoliative-encoding  genes  in
linical isolates.  In  addition,  the  antimicrobial  pat-
ern susceptibility  of  each  strain  and  the  correlation
f this  pattern  with  the  presence  of  these  genes  are
nvestigated.
aterials and methods
acterial isolates
 total  of 197  S.  aureus  strains  were  randomly
ollected from  clinical  samples,  including  wounds,
lood,  bail,  tracheal  aspirate,  sputum,  ear,  chest
ube, bronchoalveolar  lavage  (BAL),  bone,  urine,
tool, synovial  and  pleural  effusion  samples,  dur-
ng the  years  2011  and  2012  at  an  educational
ospital in  northern  Tehran,  Iran.  The  isolated  S.
ureus strains  were  conﬁrmed  using  a  gram-staining
est; catalase,  coagulase  and  DNAse  activity  tests;
 mannitol  fermentation  test  and  the  presence  of
emolysis  on  a blood  agar  plate  after  24  h growth
t 37 ◦C.  Standard  S.  aureus  strains  named  MN8  and
TCC 25923  were  applied  as  positive  and  negative
ontrols, respectively.
ntimicrobial susceptibility testing
he  antimicrobial  susceptibility  to  12  antibi-
tics, including  oxacillin  (1  g),  penicillin  G
10 Units),  vancomycin  (30  g),  ciproﬂoxacin  (5  g),
rythromycin  (15  g),  clindamycin  (2  g),  cotri-
oxazole (25  g),  gentamicin  (10  mg),  linezolid
30 mg),  cephazolin  (30  mg),  kanamycin  (30  mg)  and
etracycline (30  g),  was  evaluated  for  each  iso-
ate. The  evaluation  was  performed  using  the  disc
iffusion  method  (Kirby—Bauer)  according  to  the
LSI (Clinical  and  Laboratory  Standard  Institute)rimers  were  designed  based  on  the  eta,  etb  and
ecA  gene  sequences  of  S.  aureus  obtained  from
ene Bank  using  the  Gene  Runner  program.  To
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cxfoliative  toxin  A  and  B  genes  in  Staphylococcus  a
valuate  the  speciﬁcity  of  the  designed  primers,
hey were  analyzed  using  BLAST.  The  primer
ere synthesized  by  CinnaClon  Co.,  Iran  and
ere as  follows:  eta  forward  5′ tttgctttcttgatttg-
attc 3′,  eta  reverse  5′ gatgtgttcggtttgattgac
′,  etb  forward  5′ acggctatatacattcaatt  3′, etb
everse 5′ tccatcgataatatacctaa  3′, mecA  forward
′-tgagttgaacctggtgaagtt-3′ and  mecA  reverse
′-tggtatgtggaagttagattgg-3′. For  further  corrobo-
ation,  the  PCR  product  of  each  gene  was  analyzed
y sequencing  (Macrogen  Research,  Seoul,  Korea).
NA isolation and PCR ampliﬁcation for
ene detection
 PCR  method  was  used  to  investigate  the  distri-
ution of  the  eta,  etb  and  mecA  genes  among  the
solates.  Brieﬂy,  each  isolate  was  cultured  in  5  ml
f LB  broth  at  37 ◦C  overnight  under  aerobic  con-
itions, and  the  bacterial  cells  were  subsequently
arvested by  centrifugation  at  6000  rpm  for  10  min.
ext, 100  l  buffer  solution  (10  mM  Tris·HCl,  pH
.0; 1 mM  EDTA;  100  mM  NaCl)  and  15  l lysozyme
0.25 mg/ml)  were  added  to  the  bacterial  pellet
nd incubated  for  1  h  at  37 ◦C.  Next,  200  l  GC  solu-
ion and  15  l  proteinase  K  solution  were  added
nd incubated  for  15  min  at  60 ◦C.  Finally,  the  DNA
as precipitated  using  isopropanol.  The  quality
nd quantity  of  the  puriﬁed  DNA  were  determined
sing gel  electrophoresis  and  a  NanoDrop  spec-
rophotometer  (NanoDrop-1000,  Wilmington,  DE),
espectively.  Next,  1  l  of  each  DNA  was  ampliﬁed
n 25  l  of  reaction  mixture,  which  consisted  of  10×
eaction  buffer,  0.1  mM  deoxynucleoside  triphos-
hates (dNTPs),  2  mM  MgCl2,  10  mol  of  designed
rimers and  1  U  of  Taq  DNA  Polymerase  (Cinna-
en, Iran).  PCR  was  performed  using  the  Eppendorf
sterCycker (Hamburg,  Germany)  with  an  initial
enaturation  step  of  5  min  at  94 ◦C,  followed  by
5 cycles  of  1  min  at  94 ◦C,  2  min  at  54 ◦C,  50.9 ◦C
nd 57 ◦C  as  the  annealing  temperatures  for  the
ta, etb  and  mecA  genes,  respectively,  and  1 min
t 72 ◦C,  with  a  5  min  ﬁnal  extension  at  72 ◦C.  To
etermine the  presence  of  the  desired  amplicon,
lectrophoresis  was  performed  on  1.5%  gel  agarose
tained  with  ethidium  bromide,  and  the  products
ere  subsequently  visualized  using  a UV  transil-
uminator (Kiagene,  Iran).  The  sizes  of  the  PCR
roducts  of  the  ampliﬁed  eta,  etb  and  mecA  genes
ere 464  bp,  200  bp  and  855  bp,  respectively.
valuation of the sensitivity and speciﬁcity
f the PCR
NA  isolated  from  Staphylococcus  epidermidis,
taphylococcus  saprophyticus,  Enterococcus
e
t
o
Figure  1  The  frequency  of  patients  with  respect  to  age.
aecalis,  Clostridium  perfringens  and  Clostridium
ifﬁcile was  tested  to  assess  the  speciﬁcity  of
he designed  primers.  The  sensitivity  of  the  PCR
ests was  determined  by  preparing  two-fold  serial
ilutions  of  the  genomic  DNA  puriﬁed  from  S.
ureus  in  the  range  of  1—32  ng.  The  PCR  procedure
as performed  for  each  analysis  according  to  the
reviously  described  protocol.
tatistical analyses
o  calculate  the  correlation  between  the  preva-
ence of  the  mecA,  eta  and  etb  genes;  the  drug
esistance; and  the  demographic  properties  of  the
atients, Chi  square,  Fisher’s  exact  test  and  multi-
ariate  analysis  by  logistic  regression  using  the  SPSS
ersion 15  software  package  (Chicago,  IL)  were  per-
ormed. A  p-value  less  than  0.05  was  considered
tatistically signiﬁcant.
esults
train isolates
n  this  study,  we  evaluated  the  prevalence  of
. aureus,  which  contained  two  exfoliative  toxin
enes,  eta  and  etb,  in  the  clinical  isolates.  Of  the
97 strains,  85  (43.1%),  18  (9.13%),  nine  (4.56%),
even (35.5%),  six  (3.1%),  and  two  (1%)  were  iso-
ated from  wound,  blood,  bile,  tracheal  aspirate,
putum and  ear  samples,  respectively.  In  addition,
ne (0.5%)  strain  was  isolated  from  each  of  the
hest tube,  BAL,  bone,  urine,  stool,  plural,  and  syn-
vial samples.  Additionally,  136  (69%)  isolates  were
btained from  males,  and  the  remaining  isolates
31%) were  obtained  from  females.  The  ages  of our
ases were  in  the  range  of  1—94  years  and  were  cat-
gorized  into  10  groups.  Most  of  the  cases  belonged
o the  age  group  of  51—60  years.  The  frequency
f the  cases  with  respect  to  age  range  is  shown  in
ig.  1.
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Figure  2  Gel  electrophoresis  of  PCR  products  from  the  mecA (A),  eta  (B)  and  etb  (C)  genes.  (A)  The  size  of  the
amplicon  of  the  mecA  gene  is  855  bp.  M  indicates  the  100  bp  DNA  ladder.  Lane  1  is  the  positive  control  (S.  aureus
ATCC  43300);  lanes  2—6  show  the  results  obtained  from  clinical  isolates  and  lane  7  is  the  negative  control  (S.  aureus
ATCC  25923).  (B)  The  PCR  product  of  the  eta  gene  is  464  bp.  M:  100  bp  DNA  ladder;  lane  1:  positive  control;  lanes  2—5:
clinical  isolates  and  lane  6:  negative  control.  (C)  The  size  of  the  amplicon  of  the  etb  gene  is  200  bp.  M  indicates  the
100  bp  DNA  ladder.  Lane  1  is  the  positive  control,  lanes  2—5  show  the  results  obtained  from  clinical  isolates  and  lane
6  is  the  negative  control.
and  age  (p  =  0.054,  chi  value  3.178)  in  the  presence
of the  mecA  gene.
The  largest  numbers  of eta-positive  strains  and
etb-positive  strains  were  found  in  wound  samples
(55.8% and  6.09%,  respectively)  (Fig.  3).  None  of
the isolates  from  the  blood,  urine,  plural,  stool,  tra-
cheal aspirate,  sputum,  synovial  and  BAL  samples
contained  the  etb  gene.  The  isolated  strains  were
then divided  into  125  (91.91%)  samples  from  males
and 61  (100%)  samples  from  females  containing  eta
gene. In  addition,  14  (10.29%)  out  of  136  males  and
only one  (1.6%)  female  were  infected  by  strains
harboring the  etb  gene.  A  statistically  higher  preva-
lence of  eta-carrying  strains  were  isolated  from
female  (p =  0.019,  chi  value  5.226)  samples.  In  addi-
tion, a signiﬁcantly  higher  number  of  etb-positive
strains  was  found  in  the  samples  from  the  male  pop-
ulation (p  = 0.024,  chi  value  4.484).  No  signiﬁcant
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The  frequency  of  the  eta,  etb  and  mecA  genes
was identiﬁed  using  PCR.  In  addition,  the  rela-
tionship  of  this  frequency  with  gender,  age  and
sample  type  was  investigated.  A  representative
example of  a  PCR  reaction  for  the  identiﬁcation
of these  two  genes  is  shown  in  Fig.  2. In  addition,
the speciﬁcity  of  the  designed  primers  was  tested
via DNA  puriﬁcation  from  Staphylococcus  epider-
midis, Staphylococcus  saprophyticus,  Enterococcus
faecalis, Clostridium  perfringens  and  Clostridium
botulinum. No  PCR  product  was  obtained  from
these species.  Furthermore,  the  minimum  concen-
tration  for  the  eta  and  etb  genes  detected  by  our
designed  primers  was  2  ng.
Of the  197  isolates,  86  (94.4%),  15  (7.6%)  and
172 (86.3%)  expressed  the  eta,  etb  and  mecA  genes,
respectively.  A  deﬁciency  in  both  the  eta  and  etb
genes was  detected  in  8  (4%)  isolates.  In  addition,
14 (7.1%)  isolates  expressed  both  the  eta  and  etb
genes, and  164  (88.2%)  and  12  (80%)  strains  carrying
the eta  and  etb  genes,  respectively,  were  MRSA.
The distribution  of  the  mecA  gene  according  to
the type  of  isolates  is  shown  in  Fig.  3.  The  largest
numbers of  mecA-positive  isolates  were  isolated
from the  wound  (61.2%)  and  blood  (17.6%)  sam-
ples.  Moreover,  no  mecA  gene  was  detected  in  the
synovial  samples.  The  mecA  gene  was  detected  in
115 (84.5%)  samples  from  males  and  55  (90.1%)
samples from  females.  No  signiﬁcant  differences
were observed  between  the  sample  type  (p  = 0.3,
chi value  11.294),  gender  (p  =  0.7,  chi  value  0.112)
Type of cli nical sample
Figure  3  The  frequency  of  the  mecA, eta  and  etb  genes
among  the  isolates.
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Figure  4  Prevalence  of  the  anti-microbial  resistance  in
the  studied  population.
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1orrelation  was  demonstrated  between  the  pres-
nce of  the  genes  and  age  or  the  presence  of  the
enes and  the  source  of  the  clinical  samples  using
ultivariate  logistic  regression  analysis  (p  =  0.906,
dd ratio  = 0.162).
nti-microbial susceptibility analysis
he  antibiotic-resistant  properties  of  each  isolate
ere determined  using  antimicrobial  susceptibility
nalysis. The  highest  resistance  to  penicillin  was
bserved  among  the  isolates.  None  of  the  isolates
ere resistant  to  linezolid  and  vancomycin.  The
requency  of  resistant  isolates  to  each  antibiotic
s illustrated  in  Fig.  4. The  multidrug  resistance
resistant to  more  than  3 antibiotics)  status  of  our
solates is  summarized  in  Table  1. Statistical  analy-
es showed  no  signiﬁcant  effect  of  gender,  age  and
ample types  on  the  prevalence  of  the  multidrug
esistance properties  (p  >  0.05).
Prevalence  of  the  mecA  gene  and  the  antibi-
tic resistance  status  of  the  isolates  are  provided
n Table  2.  In  addition  to  penicillin,  ciproﬂoxacin,
ancomycin  and  linezolid,  resistance  to  other
ntibiotics increased  signiﬁcantly  in  the  presence  of
he mecA  gene  (Table  2).  Furthermore,  we  observed
hat the  presence  of  the  mecA  gene  was  signiﬁ-
antly higher  among  the  multidrug  resistant  isolates
p =  0.042,  chi  value  = 3.363)  (Table  1).  Moreover,
8 (33.7%)  of  the  MRSA  isolates  were  resistant
o all  antibiotics,  excluding  vancomycin  and  line-
olid.
Furthermore,  59  (31.7%)  isolates  harboring  theta gene  were  resistant  to  all  of  the  described
ntibiotics  except  for  vancomycin  and  linezolid
Table  2).  No  signiﬁcant  correlation  was  found T
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etween  the  resistance  to  the  examined  antibi-
tics and  the  presence  of  the  eta  gene  (p  =  0.101,
dd ratio  =  0.245).  Moreover,  there  was  no  signif-
cant correlation  between  the  distribution  of  the
ta gene  and  the  multidrug  resistance  pattern
p =  0.469,  odd  ratio  =  0.343)  (Table  1).
Except  for  penicillin,  resistance  to  all  of  the
ntibiotics tested  in  the  strains  harboring  the  etb
ene was  signiﬁcantly  lower  compared  to  the  resis-
ance in  the  strains  deﬁcient  for  the  etb  gene
p <  0.05).  In  addition,  the  MDR  property  was  sig-
iﬁcantly more  prevalent  among  the  etb  negative
trains (p  =  0.031,  chi  value  =  13.54).
iscussion
. aureus  causes  a high  rate  of  morbidity  and  mor-
ality due  to  severe  nosocomial  infections.  One  of
he major  issues  is the  emergence  of  MRSA  strains
nd their  increased  prevalence  in  some  parts  of
he world,  resulting  in  some  difﬁculties  in  their
reatment. In  addition,  the  multidrug  resistance
roperties of  MRSA  strains  and  the  production  of
arious types  of  virulence  factors  cause  the  spread
f infections.  It  has  been  proposed  that  resis-
ance to  antibiotics  can  alter  the  expression  of
enes involved  in  pathogenesis  [6]. In  this  study,
he genotyping  outcomes  demonstrated  an  exceed-
ngly high  prevalence  of  MRSA  strains  (87.6%)  as
ell as  an  elevated  rate  of  antibiotic  resistance,
hich was  nearly  similar  to  several  reports  obtained
rom China  (77.65—80%)  [7,8]. Nevertheless,  ﬁnd-
ngs obtained  from  most  studies  conﬂict  with  the
urrent  study  as  the  prevalences  of  MRSA  observa-
ions were  41.6%  (USA)  [9], 16.2%  (Nigeria)  [10]  and
8% (Russia)  [11]  in  previous  studies.
Tokajian et  al.  in  Lebanon  found  that  72%  of
solates were  MRSA,  but  a lower  prevalence  of
ultidrug  resistance  properties  (18%)  was  been
eported  [8].  However,  the  differences  in  the  pat-
ern of  mecA  gene  distribution  with  regard  to
ender and  age  remain  unclear  in  both  MRSA  and
SSA groups.  In  this  study,  the  mecA  gene  was  more
revalent  among  wound  samples.
Currently, S.  aureus  strains  that  are  resistant
o numerous  antimicrobial  drugs  are  commonly
solated from  nosocomial  infections.  The  spread
f multidrug-resistant  strains  is  one  of  the  major
roblems  of  health  committees  worldwide  due  to
he complicated  treatment  process.  In  this  study,
he frequency  of antimicrobial  resistance  was  very
igh. Our  results  showed  a high  prevalence  of  resis-
ance toward  many  antibiotics  that  are  routinely
dministered for  the  treatment  of  staphylococ-
al infection.  Similar  to  most  regions  around  the
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rxfoliative  toxin  A  and  B  genes  in  Staphylococcus  a
orld  [9—11],  resistance  to  penicillin  was  high  in
ur studied  population  (94.4%).  Despite  the  high
requency  of  MRSA  among  our  isolates,  half  of
he specimens  were  resistant  to  oxacillin,  which
as lower  than  the  amount  reported  in  Belgium
99%) [12]  and  higher  than  the  frequency  reported
n Lebanon  (32%)  [8]  and  Nigeria  (16.2%)  [10].
ccording  to  this  result,  based  on  the  oxacillin
esistance assay,  some  MRSA  strains  might  not  be
dentiﬁed using  the  screening  test.  Inconsistent
ith the  results  of  some  Asian  and  African  coun-
ries, in  which  the  percentage  of  resistance  to
rythromycin  was  lower  than  30%  [13,14]  or  was
0%) [10,11],  erythromycin-resistant  strains  were
ore abundant  in  the  current  study  (51.3%).  How-
ver, higher  prevalences  erythromycin-resistant
trains  have  been  observed  in  the  United  Kingdom
90%) [15],  China  (97.8%)  [16]  and  Australia  (98%)
17].  We  also  observed  an  enhanced  prevalence
f tetracycline-resistant  strains  (61.3%)  compared
o previous  reports  from  Lebanon  (48%  and  44%)
8,18]  and  USA  (5%)  [19]. However,  Nimmo  et  al.
nd Zhang  et  al.  reported  a  prevalence  of  80%
nd 97.8%  resistant  isolates  from  Australia  [17]
nd  China  [16],  respectively.  Moreover,  the  preva-
ence  of  gentamicin-resistant  strains  was  higher
47.7%)  than  reports  from  Nigeria  (14.7%)  [10],
hina (28.1%)  [9],  and  Russia  (19%)  [11].  In  addi-
ion,  the  rates  of  resistance  to  clindamycin  and
iproﬂoxacin  were  higher  compared  to  Russia  [11],
igeria [10],  Libya  [20]  and  Lebanon  [8]. Similar
o the  results  obtained  from  several  previous  stud-
es, the  resistance  to  vancomycin  [8,14,15,18,21]
nd  linezolid  [9,10]  was  not  observed  amongst  our
solates.
In this  study,  we  found  high  prevalences  of  eta
nd etb  genes  among  our  isolates.  However,  the
ccurrence  of  eta  was  more  frequent  than  etb.
n addition,  strains  harboring  both  of  these  genes
ere more  abundant  in  the  MRSA  population.  The
ow prevalence  of  these  genes  has  been  reported  in
any countries  worldwide.  Xie  and  colleagues  have
reviously  observed  a  low  frequency  of  this  gene
22].  In  another  Chinese  study,  the  eta  gene  was
etected  in  only  one  child  [23].  Most  of  the  isolates
f these  two  studies  were  collected  from  sputum.
n contrast  with  the  reports  from  China,  acces-
ible ﬁndings  from  Czech  [24], Germany  [25,26],
witzerland  [27]  and  Malaysia  found  a  low  preva-
ence of  genes  encoding  exfoliative  toxin  isoforms.
n all  of  the  studies  mentioned  above,  the  num-
er of  wound  samples  was  low.  In  another  study
rom Colombia,  which  investigated  the  distribution
f the  eta  and  etb  genes  among  pediatric  patients,
nly 2%  of  the  isolates  carried  eta,  but  no  strain
arried the  etb  gene  [28]. Similar  to  our  study,  the
A
T
Rs  183
ajority  of  specimens  collected  by  Demir  et  al.
29], and  Liu  et  al.  [16]  were  obtained  from  wound
nd blood.  Demir  and  colleagues  found  the  eta  and
tb genes  among  19.2%  and  9.2%  of  cases,  respec-
ively. Consistent  with  these  ﬁndings,  43.1%  of  the
solates were  recovered  from  wound  samples  in  the
urrent study.
Similar to  most  staphylococcal  virulence  factors,
xfoliative  toxins  play  a  role  in  host  colonization
nd the  invasion  of  injured  mucosa  and  skin.  Thus,
he high  rates  of  exfoliative  toxin  genes  in  this
tudy  could  be  due  to  the  high  frequency  of  wound
pecimens.  Our  results  demonstrate  three  impor-
ant ﬁndings.  First,  the  percentage  of  MRSA  strains
nd consequent  multidrug  resistance  has  increased
n our  population.  Second,  independent  of  the  SSSS
atients’  shortage  among  our  isolates,  remarkably
igh rates  of  eta  and  etb  were  found.  In addition,
heir distribution  was  similar  in  both  the  MRSA  and
ethicillin-sensitive  S.  aureus  (MSSA)  groups.  Last,
rug resistance  was  abundant  in  the  analyzed  pop-
lation.
Despite the  geographical  variations,  data
btained from  various  regions  worldwide  indicate
 higher  distribution  of  eta  compared  to  etb,
hich  could  be  due  to  the  great  immunogenicity  of
TA [8]. Importantly,  the  presence  of  toxin  genes
oes not  demonstrate  the  level  of related  protein
xpression. However,  among  our  population,  no
ase of  SSSS  was  detected.  This  observation  sug-
ested an  insufﬁcient  amount  of toxins  that  could
ot have  caused  the  disease.  It  is  thought  that
ore antibiotic  resistance  is  acquired,  and  lower
irulence  factor  was  secreted  [6,30]. Thus,  as  a
onsequence  of  the  signiﬁcantly  high  rate  of  drug
esistance  among  our  isolates,  it  is  possible  that
he expression  of  these  two  genes  is  reduced.  In
ddition,  the  presence  of  the  eta  and  etb  genes  in
amples from  damaged  tissues  (such  as  a wound
ite) is an  indicator  for  increased  susceptibility  of
he patient  to  harmful  diseases,  such  as  SSSS.
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